Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational Progress
Go back to Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational Progress| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.58 +0.05 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.53 | 52 Week High | $4.76 | |||
| Open | $2.55 | 52 Week Low | $1.46 | |||
| Day High | $2.63 | P/E | N/A | |||
| Day Low | $2.51 | EPS | $-1.91 | |||
| Volume | 1,664,017 | |||||
